ClinicalTrials.gg
CompletedNCT06348953Updated Jun 3, 2026

Bioactive Versus Non-Bioactive Restorative System in Deep Carious Molars

An interventional study of selective caries removal and conventional non-bioactive restorative system and selective caries removal and bioactive restorative system in Dental Caries, Dental Diseases and Deep Caries, sponsored by Cairo University. Completed at 1 site in Egypt. Open to participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-06-03.

Sponsored by Cairo University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
18 Years to 40 Years
Sex
All
01

Study summary

This research study delves into the effectiveness of bioactive and non-bioactive restorative systems in deep carious permanent molars treated with selective caries removal. Selective caries removal techniques aim to preserve as much healthy tooth structure as possible while effectively eliminating carious tissue. The study investigates how the choice of restorative material influences the outcomes of selective caries removal procedures in deep carious lesions. By assessing factors such as restoration integrity, pulpal response, and long-term success rates, the research seeks to provide evidence-based insights into the comparative performance of bioactive and non-bioactive restorative systems in this clinical context.

Read the detailed description

Deep carious lesions in permanent molars present a significant challenge in restorative dentistry. Traditional approaches to caries removal often involve the removal of excessive healthy tooth structure, leading to weakened teeth and potential pulp exposure. Selective caries removal techniques aim to preserve as much healthy tooth structure as possible while effectively eliminating carious tissue, offering a conservative alternative to traditional methods. In recent years, bioactive restorative materials have emerged as promising alternatives to conventional non-bioactive materials. Bioactive materials are designed to interact with the biological environment, promoting remineralization and potentially enhancing the longevity of restorations. However, limited evidence exists comparing the efficacy of bioactive and non-bioactive restorative systems in deep carious lesions treated with selective caries removal. This study is designed as a prospective, randomized controlled trial. Patients presenting with deep carious lesions in permanent molars will be randomly allocated to receive either a bioactive or non-bioactive restorative system following selective caries removal. Baseline demographic and clinical data will be recorded for each participant. Clinical evaluations will be conducted at regular intervals over a follow-up period of months. Outcome measures will include restoration integrity (e.g retention, marginal adaptation), pulpal response (e.g., sensitivity, vitality).

02

Conditions studied

  • Dental Caries
  • Dental Diseases
  • Deep Caries
  • Tooth Diseases
  • Tooth Decay
  • Teeth; Lesion
  • Caries; Dentin
  • Dental Restoration Failure of Marginal Integrity
  • Tooth Demineralization

Keywords

  • self-etch adhesive
  • deep caries in permanent molars
  • bioactive restorative system
  • selective caries removal
  • partial caries removal
  • selective removal to soft caries
  • bioactive adhesive
  • bioactive bond
  • bioactivity
  • deep carious molars
  • rct
03

In context

Dental Caries

1,171 studies on the registry are indexed under Dental Caries; 209 are open to participants now.

This study's enrollment of 50 is below the median of 60 across 967 interventional studies indexed under Dental Caries.

Browse Dental Caries studies →

Lead sponsor

Cairo University is the lead sponsor of 4,941 studies on the registry; 1,458 are open to participants now.

Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • young adult patients (age: 18-40 years) of both genders.
  • Able to tolerate necessary restorative procedures.
  • Willing to sign the .
  • Accepts the follow-up period.
  • Posterior permanent tooth with occlusal proximal deep carious lesion.
  • Radiographically (bitewing radiograph) extending to the inner 1/3 of dentine (D3) with a radiopaque layer between the carious lesion and the pulp chamber.
  • Sensible teeth according to cold pulp test.

Exclusion criteria

Exclusion criteria:

  • Allergy to any restorative materials.
  • Patients undergoing orthodontic treatment with fixed appliances.
  • Pregnant women.
  • Patients with debilitating systemic diseases
  • Teeth with previous restorations.
  • Spontaneous pain or prolonged pain (more than 15 s) after sensitivity test (cold test), which would indicate irreversible pulpitis.
  • Negative sensibility tests, periapical radiolucencies and sensitivity to axial or lateral percussion.
  • Mobile teeth, indicating periodontal disease or trauma.
  • External or internal resorption.
  • Cervical carious lesions.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
50 participants (actual)

Study arms

  • Active comparator
    Conventional non-bioactive restorative system (Comparator)

    deep carious molars restored with conventional resin based restorative system

    Other: selective caries removal and conventional non-bioactive restorative system

  • Active comparator
    Bioactive system (Intervention)

    deep carious molars restored with bioactive resin based restorative system

    Other: selective caries removal and bioactive restorative system

Interventions

  • Otherselective caries removal and conventional non-bioactive restorative system

    conventional dental restorative adhesive and resin based composite

  • Otherselective caries removal and bioactive restorative system

    bioactive dental restorative resin based system

06

What researchers measure

Primary outcomes

  1. Biological properties - Post Operative Hypersensitivity and Vitality-Success rate%-Scoring system:Ordinal1-5

    1. excellent(No hypersensitivity,normal vitality 2. good(Minor hypersensitivity for a limited time,normal vitality 3. satisfactory(Moderate hypersensitivity-Delayed/mild sensitivity;no subjective complaints,no treatment needed 4. unsatisfactory(Intense hypersensitivity-Delayed with minor subjective symptoms-No detectable sensitivity-Intervention necessary but not replacement 5. poor(Intense, acute pulpitis or non-vital tooth-Endodontic treatment is necessary and restoration replacement

    Time frame: 18 months

Secondary outcomes

  1. Functional properties - (fracture and retention)

    1. excelent Frac\&Ret:No fractures /Cracks 2. good Frac\&Ret:Small hairline crack 3. satisfactory Fract and Ret:Two or more or larger hairline cracks and/or material chip fracture not affecting the marginal integrity or approximal contact 4. unsatisfactory Fract and Ret:Material chip damage marginal quality-approximal contacts-Bulk fracture\& partial loss-less than half of restoration 5. poor Fracture and Retention:(Partial-complete loss of resto. or multiple fractures)

    Time frame: 18 months

  2. Functional properties - Approximal anatomical form (contact point and contour)

    1. excelent Approximal anatomical form (a. contact point b. contour): Normal contact point (floss or 25 μm metal blade can pass) and Normal contour. 2. good Approximal anatomical form (a. contact point b. contour): Contact slightly too strong but no disadvantage (floss or 25 μm metal blade can only pass with pressure) and slightly deficient contour. 3. satisfactory Approximal anatomical form: (a. contact point b. contour): Somewhat weak contact, no indication of damage to tooth, gingiva or periodontal structures; 50 μm metal blade can pass and visible deficient contour 4. unsatisfactory Approximal anatomical form: (a.contact point b.contour)Too weak and possible damage due to food impaction;100 μm metal blade can pass and Inadequate contour (Repairable) 5. poor Approx. anatomical form (a.contact point b.contour):Too weak and/or clear damage due to food impaction and/or pain/gingivitis with insufficient contour requires replacement.

    Time frame: 18 months

  3. continue Functional properties (Radiographic Examination -when applicable)

    1. excelent xray:No pathology,harmonious transition between restoration \&Tooth 2. good xray:Acceptable material excess present-Positive/negative step present at margin \<150 μm 3. satisfactory xray:Marginal gap\<250 μm-Negative steps visible\<250 Μm-No adverse effects Noticed-Poor radiopacity of filling 4. unsatisfactory xray:(Marginal gap \>250 μm)(Material excess accessible but not removable)(Negative steps \>250μm and reparable) 5. poor xray:(Secondary caries, large gaps, large overhangs) (Apical pathology) (Fracture/loss of restoration or tooth).

    Time frame: 18 months

  4. continue Functional properties ( marginal adaptation )

    1. excelent Marginal Adaptation:Harmonious outline,no gaps,white or discolored lines 2. good Marginal Adaptation:Marginal gap(\<150 μm),white line-Small marginal fracture removable by polishing-Slight ditching,slight step/flashes,minor irregularities 3. satisfactory Marginal Adaptation:Gap\<250μm not removable-Several small marginal fractures-Major irregularities,ditching or flash,steps 4. unsatisfactory Marginal Adapt.:Gap\>250μm or dentine/base exposed-Severe ditching or marginal fract. - Larger irregularities or steps -repair necessary 5. poor Marginal Adaptation:Restoration-complete or partial-is loose but in situ-Generalized major gaps or irregularities.

    Time frame: 18 months

  5. Biological properties (Recurrence of caries (CAR), erosion, abfraction- Scoring system Ordinal 1-5)

    1. = excellent (No secondary or primary caries) 2. = good (Small and localized 1.Demineralization 2. Erosion or 3. Abfraction) 3. = satisfactory (Larger areas of 1.Demineralisation 2. Erosion or 3. Abrasion/abfraction, dentine not exposed) (Only preventive measures necessary) 4. = unsatisfactory (Caries with cavitation and suspected undermining caries) (Erosion in Dentine) (Abrasion/abfraction in dentine) (Localized and accessible can be repaired). 5. = poor (Deep caries or exposed dentine that is not accessible for repair of restoration)

    Time frame: 18 months

  6. Success or Failure

    Binary Outcome Success (Score 1,2\&3) Failure (Score 4 \&5)

    Time frame: 18 months

07

Study locations

1 site
  • Faculty of Dentistry - Cairo University
    Cairo, Egypt
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jun 2024 to primary completion in Dec 2025, 18 months.

Of 469 non-industry interventional studies with no phase under Dental Caries, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 30. This study's 18 months is above that.

Counting every sponsor, half of 502 studies reached it within 15 months; a quarter within 7 and three quarters within 29.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 20, 2024
First posted
Apr 5, 2024
StartActual
Jun 1, 2024
Primary completionActual
Dec 10, 2025
CompletionActual
Mar 15, 2026
Last update
Jun 3, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 3, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06348953
Lead sponsor
Cairo University
Responsible party
Ahmed Mahmoud Ahmed Mohammed (General practitioner, Cairo University) — Principal investigator
First posted
Apr 5, 2024
Start date
Jun 1, 2024
Primary completion
Dec 10, 2025
Completion
Mar 15, 2026
Last update
Jun 3, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion